Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-001872
Filing Date
2023-06-23
Accepted
2023-06-23 16:03:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3318
  Complete submission text file 0001950047-23-001872.txt   4773
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Subject) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37686 | Film No.: 231037628
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD, SUITE 100 AUSTIN VI 78729
Business Address
Sanders Corazon (Corsee) D. (Reporting) CIK: 0001796536 (see all company filings)

Type: 144